Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16381996 | 0.83 | CDA (0.39) | CDA | |
| SCHEMBL20427403 | 0.83 | CDA (0.39) | CDA | |
| SCHEMBL18798692 | 0.82 | CDA (0.33) | CDA | |
| SCHEMBL19229350 | 0.77 | CDA (0.39) | CDA | |
| SCHEMBL26311383 | 0.76 | CDA (0.48) | CDA | |
| SCHEMBL17232101 | 0.76 | CYP3A4 (0.30) | — | |
| SCHEMBL16125739 | 0.76 | CDA (0.31) | CDA | |
| SCHEMBL14583693 | 0.75 | ADORA2A (0.38) | CDA | |
| SCHEMBL15187536 | 0.75 | ADORA2A (0.38) | CDA | |
| SCHEMBL18875014 | 0.75 | ADORA2A (0.38) | CDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170247404-A1 | PROCESS FOR THE PREPARATION OF SOFOSBUVIR | HC-PHARMA AG (CH) | 2017-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170247404-A1 | PROCESS FOR THE PREPARATION OF SOFOSBUVIR | SAMHD1, CYP3A4, CYP3A5 | CDA 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.